Merck held talks to buy Swiss biotech MoonLake for more than $3bn
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this…
Cash in on the biotech boom with three European stocks
Biotechnology companies have been a cornerstone of the pharmaceutical industry since the mid-1990s. Today, many of these firms…
Chinese biotech PegBio’s shares fall 13% on Hong Kong IPO debut
PegBio, a Hangzhou-headquartered Chinese biotech firm, made its debut on the main board of the Hong Kong…
Why now is the right time to invest in biotech
We are living in a golden age of innovation in medical sciences. Biotech companies focused on the development…
Major biotech company acquired after Chapter 11 bankruptcy
It has become oddly normal for people to put their DNA in a tube and mail it off…
Supporting career development in the biotech space
We spoke with Amgen’s Philip Ryan about his role in the ever-evolving biotech sector and his advice for…
Top 3 Biotech Stocks to Watch in 2025 for Big Gains
The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no…
Investor Caution Leads to Dip in Biotech Financings, GlobalData Report Shows
The numbers for first quarter 2025 biotech financings are in and they show a downturn in investments. A…
Vinay Prasad’s Appointment To FDA’s CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation – Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC), Capricor Therapeutics (NASDAQ:CAPR)
FDA Commissioner Marty Makary on Tuesday named Vinay Prasad the next director of the U.S. Food and Drug…
Exclusive: Biotech startup Profluent says it has found “scaling laws” for AI models for protein design
A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new…